investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Manoj Menon

0 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Improve clinical care outcomes via phase1/2 study that is evaluating the use of Brentuximab Vedontin in combination with chemotherapy.

Related projects

Saro Armenian

Anthraycline-Related Cardiotoxicity in Long-Term Survivors of Lymphoma

Hodgkin lymphoma

Hematology and hematologic malignancies

Martin G Pomper

BETR Therapy for Herpesvirus-Associated Tumors

Hodgkin lymphoma

Hematology and hematologic malignancies

Helen E. Heslop

SPORE in Lymphoma

Hodgkin lymphoma

Hematology and hematologic malignancies

Ulf Klein

The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis

Hodgkin lymphoma

Hematology and hematologic malignancies

Leona W Ayers

Mid-Region Aids and Cancer Specimen Resource Consortium

Hodgkin lymphoma

Hematology and hematologic malignancies

Frederick Appelbaum

Adult Leukemia Research Center

Hodgkin lymphoma

Hematology and hematologic malignancies

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Hodgkin lymphoma

Hematology and hematologic malignancies

Henry Ddungu

The Optimal Use of Platelet Support Transfusion Among Patients with Hematological Malignancies in Uganda

Hodgkin lymphoma

Hematology and hematologic malignancies

Effie W Petersdorf

Hematopoietic Stem Cell and Cord Blood Transplantation

Hodgkin lymphoma

Hematology and hematologic malignancies